Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Downgrades Kazia Therapeutics to Neutral

HC Wainwright & Co. analyst Sean Lee downgrades Kazia Therapeutics (NASDAQ:KZIA) from Buy to Neutral.
byBenzinga Newsdesk
August 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Sean Lee downgrades Kazia Therapeutics (NASDAQ:KZIA) from Buy to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Expert Ratings for Expedia Group

By Benzinga Insights
August 19, 11:01 AM
Over the past 3 months, 14 analysts have published their opinion on Expedia Group (NASDAQ:EXPE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

EXPE